다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
The Lancet, v.387 no.10022 = no.10022, 2016년, pp.999 - 1011
Mol, B.W.J. , Roberts, C.T. , Thangaratinam, S. , Magee, L.A. , de Groot, C.J.M. , Hofmeyr, G.J.
AI-Helper
Pre-eclampsia affects 3-5% of pregnancies and is traditionally diagnosed by the combined presentation of high blood pressure and proteinuria. New definitions also include maternal organ dysfunction, such as renal insufficiency, liver involvement, neurological or haematological complications, uteropl...
BMJ Ananth 347 f6564 2013 10.1136/bmj.f6564 Pre-eclampsia rates in the United States, 1980-2010: age-period-cohort analysis
Bull World Health Organ Saleem 92 605 2014 10.2471/BLT.13.127464 A prospective study of maternal, fetal and neonatal deaths in low- and middle-income countries
Lancet Souza 381 1747 2013 10.1016/S0140-6736(13)60686-8 Moving beyond essential interventions for reduction of maternal mortality (the WHO Multicountry Survey on Maternal and Newborn Health): a cross-sectional study
J Pediatr Hansen 156 532 2010 10.1016/j.jpeds.2009.10.018 Maternal preeclampsia predicts the development of bronchopulmonary dysplasia
BMJ Strand 347 f4089 2013 10.1136/bmj.f4089 Mediators of the association between pre-eclampsia and cerebral palsy: population based cohort study
Eur J Obstet Gynecol Reprod Biol Prick 185 88 2015 10.1016/j.ejogrb.2014.11.038 Determinants of health-related quality of life in the postpartum period after obstetric complications
BJOG Blom 117 1390 2010 10.1111/j.1471-0528.2010.02660.x Perinatal complications increase the risk of postpartum depression. The Generation R Study
Best Pract Res Clin Obstet Gynaecol Williams 25 405 2011 10.1016/j.bpobgyn.2011.02.007 The genetics of pre-eclampsia and other hypertensive disorders of pregnancy
Hypertension Rana 63 198 2014 10.1161/HYPERTENSIONAHA.113.02293 Angiogenic factors in diagnosis, management, and research in preeclampsia
Biochim Biophys Acta Jebbink 1822 1960 2012 10.1016/j.bbadis.2012.08.004 Molecular genetics of preeclampsia and HELLP syndrome-a review
Hum Reprod Update Buurma 19 289 2013 10.1093/humupd/dms060 Genetic variants in pre-eclampsia: a meta-analysis
Int J Epidemiol Staines-Urias 41 1764 2012 10.1093/ije/dys162 Genetic association studies in pre-eclampsia: systematic meta-analyses and field synopsis
Am J Epidemiol Fong 180 335 2014 10.1093/aje/kwu151 Maternal genotype and severe preeclampsia: a HuGE review
J Exp Med Hiby 200 957 2004 10.1084/jem.20041214 Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success
Proc Natl Acad Sci USA Nakimuli 112 845 2015 10.1073/pnas.1413453112 A KIR B centromeric region present in Africans but not Europeans protects pregnant women from pre-eclampsia
Placenta Long 36 433 2015 10.1016/j.placenta.2014.05.008 Association of maternal KIR and fetal HLA-C genes with the risk of preeclampsia in the Chinese Han population
Nat Med Venkatesha 12 642 2006 10.1038/nm1429 Soluble endoglin contributes to the pathogenesis of preeclampsia
Pregnancy Hypertens Tranquilli 4 97 2014 10.1016/j.preghy.2014.02.001 The classification, diagnosis and management of the hypertensive disorders of pregnancy: A revised statement from the ISSHP
J Obstet Gynaecol Can Magee 30 suppl S1 2008 10.1016/S1701-2163(16)32776-1 Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy
2011 Hypertension in pregnancy. NICE clinical guideline 107
Obstet Gynecol 122 1122 2013 10.1097/01.AOG.0000437382.03963.88 Hypertension in Pregnancy
Hypertens Pregnancy Brown 30 188 2011 10.3109/10641955.2010.507854 Can we use the Omron T9P automated blood pressure monitor in pregnancy?
Hypertens Pregnancy Nouwen 31 131 2012 10.3109/10641955.2010.544799 Validation of the Omron M7 and Microlife 3BTO-A blood pressure measuring devices in preeclampsia
BMJ Glasziou 334 349 2007 10.1136/bmj.39070.527986.68 When are randomised trials unnecessary? Picking signal from noise
Hypertension Staff 61 932 2013 10.1161/HYPERTENSIONAHA.111.00250 Redefining preeclampsia using placenta-derived biomarkers
BMJ Bramham 348 g2301 2014 10.1136/bmj.g2301 Chronic hypertension and pregnancy outcomes: systematic review and meta-analysis
BMJ Roos 343 d6309 2011 10.1136/bmj.d6309 Risk of adverse pregnancy outcomes in women with polycystic ovary syndrome: population based cohort study
N Engl J Med Garg 372 124 2015 10.1056/NEJMoa1408932 Gestational hypertension and preeclampsia in living kidney donors
Best Pract Res Clin Obstet Gynaecol Leslie 25 343 2011 10.1016/j.bpobgyn.2011.01.002 Early prediction and prevention of pre-eclampsia
BMJ North 342 d1875 2011 10.1136/bmj.d1875 Clinical risk prediction for pre-eclampsia in nulliparous women: development of model in international prospective cohort
N Engl J Med Levine 350 672 2004 10.1056/NEJMoa031884 Circulating angiogenic factors and the risk of preeclampsia
Clin Chem Hagmann 58 837 2012 10.1373/clinchem.2011.169094 The promise of angiogenic markers for the early diagnosis and prediction of preeclampsia
Circulation Chappell 128 2121 2013 10.1161/CIRCULATIONAHA.113.003215 Diagnostic accuracy of placental growth factor in women with suspected preeclampsia: a prospective multicenter study
Eur J Obstet Gynecol Reprod Biol Allen 182 194 2014 10.1016/j.ejogrb.2014.09.027 Abnormal blood biomarkers in early pregnancy are associated with preeclampsia: a meta-analysis
Hypertension Poon 53 812 2009 10.1161/HYPERTENSIONAHA.108.127977 First-trimester prediction of hypertensive disorders in pregnancy
Ultrasound Obstet Gynecol Velauthar 43 500 2014 10.1002/uog.13275 First-trimester uterine artery Doppler and adverse pregnancy outcome: a meta-analysis involving 55,974 women
BJOG Kleinrouweler 119 778 2012 10.1111/j.1471-0528.2012.03311.x Accuracy of circulating placental growth factor, vascular endothelial growth factor, soluble fms-like tyrosine kinase 1 and soluble endoglin in the prediction of pre-eclampsia: a systematic review and meta-analysis
BJOG Myatt 120 1183 2013 10.1111/1471-0528.12128 Can changes in angiogenic biomarkers between the first and second trimesters of pregnancy predict development of pre-eclampsia in a low-risk nulliparous patient population?
Hypertension Kenny 64 644 2014 10.1161/HYPERTENSIONAHA.114.03578 Early pregnancy prediction of preeclampsia in nulliparous women, combining clinical risk and biomarkers: the Screening for Pregnancy Endpoints (SCOPE) international cohort study
Hypertension Kenny 56 741 2010 10.1161/HYPERTENSIONAHA.110.157297 Robust early pregnancy prediction of later preeclampsia using metabolomic biomarkers
Lancet Askie 369 1791 2007 10.1016/S0140-6736(07)60712-0 Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data
Cochrane Database Syst Rev Dodd 7 2013 10.1002/14651858.CD006780.pub3 Antithrombotic therapy for improving maternal or infant health outcomes in women considered at risk of placental dysfunction
Cochrane Database Syst Rev Hofmeyr 6 2014 10.1002/14651858.CD001059.pub4 Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems
Am J Obstet Gynecol Conde-Agudelo 204 503 2011 10.1016/j.ajog.2011.02.020 Supplementation with vitamins C and E during pregnancy for the prevention of preeclampsia and other adverse maternal and perinatal outcomes: a systematic review and metaanalysis
Cochrane Database Syst Rev Makrides 4 2014 10.1002/14651858.CD000937.pub2 Magnesium supplementation in pregnancy
J Hum Hypertens Dorniak-Wall 28 230 2014 10.1038/jhh.2013.100 The role of L-arginine in the prevention and treatment of pre-eclampsia: a systematic review of randomised trials
Cochrane Database Syst Rev De-Regil 2 2012 10.1002/14651858.CD008873.pub2 Vitamin D supplementation for women during pregnancy
BMJ Thangaratinam 344 e2088 2012 10.1136/bmj.e2088 Effects of interventions in pregnancy on maternal weight and obstetric outcomes: meta-analysis of randomised evidence
BMJ Dodd 348 g1285 2014 10.1136/bmj.g1285 Antenatal lifestyle advice for women who are overweight or obese: LIMIT randomised trial
J Nutr Brantsaeter 139 1162 2009 10.3945/jn.109.104968 A dietary pattern characterized by high intake of vegetables, fruits, and vegetable oils is associated with reduced risk of preeclampsia in nulliparous pregnant Norwegian women
Lancet Rodger 384 1673 2014 10.1016/S0140-6736(14)60793-5 Antepartum dalteparin versus no antepartum dalteparin for the prevention of pregnancy complications in pregnant women with thrombophilia (TIPPS): a multinational open-label randomised trial
J Thromb Haemost de Vries 10 64 2012 10.1111/j.1538-7836.2011.04553.x Low-molecular-weight heparin added to aspirin in the prevention of recurrent early-onset pre-eclampsia in women with inheritable thrombophilia: the FRUIT-RCT
BMC Pregnancy Childbirth Ephraim 14 390 2014 10.1186/s12884-014-0390-2 Serum calcium and magnesium levels in women presenting with pre-eclampsia and pregnancy-induced hypertension: a case-control study in the Cape Coast metropolis, Ghana
BJOG Hofmeyr 114 933 2007 10.1111/j.1471-0528.2007.01389.x Dietary calcium supplementation for prevention of pre-eclampsia and related problems: a systematic review and commentary
Cochrane Database Syst Rev Hofmeyr 8 2010 10.1002/14651858.CD001059.pub3 Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems
Hofmeyr
Cochrane Database Syst Rev Makrides 3 2006 10.1002/14651858.CD003402.pub2 Marine oil, and other prostaglandin precursor, supplementation for pregnancy uncomplicated by pre-eclampsia or intrauterine growth restriction
BMJ Aghajafari 346 f1169 2013 10.1136/bmj.f1169 Association between maternal serum 25-hydroxyvitamin D level and pregnancy and neonatal outcomes: systematic review and meta-analysis of observational studies
BMJ Vadillo-Ortega 342 d2901 2011 10.1136/bmj.d2901 Effect of supplementation during pregnancy with L-arginine and antioxidant vitamins in medical food on pre-eclampsia in high risk population: randomised controlled trial
Cochrane Database Syst Rev Meher 2 2007 10.1002/14651858.CD006490 Nitric oxide for preventing pre-eclampsia and its complications
Acta Obstet Gynecol Scand Allen 93 973 2014 10.1111/aogs.12467 Effect of diet- and lifestyle-based metabolic risk-modifying interventions on preeclampsia: a meta-analysis
Lancet von Dadelszen 377 219 2011 10.1016/S0140-6736(10)61351-7 Prediction of adverse maternal outcomes in pre-eclampsia: development and validation of the fullPIERS model
Am J Obstet Gynecol Habli 201 385 2009 10.1016/j.ajog.2009.06.033 Long-term maternal and subsequent pregnancy outcomes 5 years after hemolysis, elevated liver enzymes, and low platelets (HELLP) syndrome
Acta Obstet Gynecol Scand Thangaratinam 90 564 2011 10.1111/j.1600-0412.2011.01111.x How accurate are maternal symptoms in predicting impending complications in women with preeclampsia? A systematic review and meta-analysis
Arch Dis Child Fetal Neonatal Ed Thangaratinam 96 101 2011 10.1136/adc.2011.300163.15 What is the accuracy of blood pressure in predicting complications in pre-eclampsia?
Lancet Turnbull 363 1104 2004 10.1016/S0140-6736(04)15893-5 Clinical, psychosocial, and economic effects of antenatal day care for three medical complications of pregnancy: a randomised controlled trial of 395 women
BMC Med Thangaratinam 7 10 2009 10.1186/1741-7015-7-10 Estimation of proteinuria as a predictor of complications of pre-eclampsia: a systematic review
Acta Obstet Gynecol Scand Thangaratinam 90 574 2011 10.1111/j.1600-0412.2011.01112.x Accuracy of liver function tests for predicting adverse maternal and fetal outcomes in women with preeclampsia: a systematic review
BJOG Thangaratinam 113 369 2006 10.1111/j.1471-0528.2006.00908.x Accuracy of serum uric acid in predicting complications of pre-eclampsia: a systematic review
PLoS Med Payne 11 e1001589 2014 10.1371/journal.pmed.1001589 A risk prediction model for the assessment and triage of women with hypertensive disorders of pregnancy in low-resourced settings: the miniPIERS (Pre-eclampsia Integrated Estimate of RiSk) multi-country prospective cohort study
BMJ Morris 345 e4342 2012 10.1136/bmj.e4342 Diagnostic accuracy of spot urinary protein and albumin to creatinine ratios for detection of significant proteinuria or adverse pregnancy outcome in patients with suspected pre-eclampsia: systematic review and meta-analysis
Hypertens Pregnancy Koopmans 30 433 2011 10.3109/10641955.2010.506236 Risk indicators for eclampsia in gestational hypertension or mild preeclampsia at term
J Obstet Gynaecol Can Laskin 33 900 2011 10.1016/S1701-2163(16)35015-0 The role of platelet counts in the assessment of inpatient women with preeclampsia
Pregnancy Hypertens Magee 4 105 2014 10.1016/j.preghy.2014.01.003 Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy
Cochrane Database Syst Rev Duley 7 2013 10.1002/14651858.CD001449.pub3 Drugs for treatment of very high blood pressure during pregnancy
Obstet Med Lakshmi 5 171 2012 10.1258/om.2012.120010 Oral nifedipine versus intravenous labetalol inhypertensive urgencies and emergencies of pregnancy: a randomized clinical trial
Pregnancy Hypertens Saudan 2 182 2012 10.1016/j.preghy.2012.04.015 OS014. Which first-line drug to control severe hypertension in pregnancy? A pilot study
Am J Obstet Gynecol Vermillion 181 858 1999 10.1016/S0002-9378(99)70314-5 A randomized, double-blind trial of oral nifedipine and intravenous labetalol in hypertensive emergencies of pregnancy
BJOG Firoz 121 1210 2014 10.1111/1471-0528.12737 Oral antihypertensive therapy for severe hypertension in pregnancy and postpartum: a systematic review
Cochrane Database Syst Rev Abalos 2 2014 10.1002/14651858.CD002252.pub3 Antihypertensive drug therapy for mild to moderate hypertension during pregnancy
J Obstet Gynaecol Can Lalani 35 215 2013 10.1016/S1701-2163(15)30993-2 Pharmacotherapy for preeclampsia in low and middle income countries: an analysis of essential medicines lists
Am J Obstet Gynecol Orbach 208 e1 2013 10.1016/j.ajog.2012.11.011 Hypertension and antihypertensive drugs in pregnancy and perinatal outcomes
PLoS One Gillon 9 e113715 2014 10.1371/journal.pone.0113715 Hypertensive disorders of pregnancy: a systematic review of international clinical practice guidelines
Lancet Altman 359 1877 2002 10.1016/S0140-6736(02)08778-0 Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial
Cochrane Database Syst Rev Woudstra 9 2010 10.1002/14651858.CD008148.pub2 Corticosteroids for HELLP (hemolysis, elevated liver enzymes, low platelets) syndrome in pregnancy
J Matern Fetal Neonatal Med Everett 25 50 2012 10.3109/14767058.2011.557791 Drug development in preeclampsia: a ‘no go’ area?
Obstet Gynecol Lorenz 124 377 2014 10.1097/AOG.0000000000000399 What is new in bed rest in pregnancy? Best articles from the past year
2011 WHO recommendations for prevention and treatment of pre-eclampsia and eclampsia
Am J Obstet Gynecol Magee 193 153 2005 10.1016/j.ajog.2004.11.059 Therapy with both magnesium sulfate and nifedipine does not increase the risk of serious magnesium-related maternal side effects in women with preeclampsia
N Engl J Med Magee 372 407 2015 10.1056/NEJMoa1404595 Less-tight versus tight control of hypertension in pregnancy
Obstet Gynecol Alexander 108 826 2006 10.1097/01.AOG.0000235721.88349.80 Selective magnesium sulfate prophylaxis for the prevention of eclampsia in women with gestational hypertension
BMC Pregnancy Childbirth Bain 13 195 2013 10.1186/1471-2393-13-195 Maternal adverse effects of different antenatal magnesium sulphate regimens for improving maternal and infant outcomes: a systematic review
BMC Pregnancy Childbirth Smith 13 34 2013 10.1186/1471-2393-13-34 An integrative review of the side effects related to the use of magnesium sulfate for pre-eclampsia and eclampsia management
Cochrane Database Syst Rev Duley 8 2010 Alternative magnesium sulphate regimens for women with pre-eclampsia and eclampsia
Reprod Health Katz 10 28 2013 10.1186/1742-4755-10-28 COHELLP: collaborative randomized controlled trial on corticosteroids in HELLP syndrome
Obstet Gynecol 125 521 2015 10.1097/01.AOG.0000460762.59152.d7 Committee Opinion No. 623: Emergent therapy for acute-onset, severe hypertension during pregnancy and the postpartum period
Lancet Koopmans 374 979 2009 10.1016/S0140-6736(09)60736-4 Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks' gestation (HYPITAT): a multicentre, open-label randomised controlled trial
BJOG Tajik 119 1123 2012 10.1111/j.1471-0528.2012.03405.x Should cervical favourability play a role in the decision for labour induction in gestational hypertension or mild pre-eclampsia at term? An exploratory analysis of the HYPITAT trial
Lancet Jozwiak 378 2095 2011 10.1016/S0140-6736(11)61484-0 Foley catheter versus vaginal prostaglandin E2 gel for induction of labour at term (PROBAAT trial): an open-label, randomised controlled trial
BMJ Alfirevic 350 h217 2015 10.1136/bmj.h217 Labour induction with prostaglandins: a systematic review and network meta-analysis
Lancet Broekhuijsen 385 2492 2015 10.1016/S0140-6736(14)61998-X Immediate delivery versus expectant monitoring for hypertensive disorders of pregnancy between 34 and 37 weeks of gestation (HYPITAT-II): a multicentre, open-label, randomised controlled trial
Am J Obstet Gynecol Vigil-De Gracia 209 425 2013 10.1016/j.ajog.2013.08.016 Expectant management of severe preeclampsia remote from term: the MEXPRE Latin Study, a randomized, multicenter clinical trial
Circulation Rana 125 911 2012 10.1161/CIRCULATIONAHA.111.054361 Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia
Cochrane Database Syst Rev Brownfoot 8 2013 10.1002/14651858.CD006764.pub3 Different corticosteroids and regimens for accelerating fetal lung maturation for women at risk of preterm birth
Obstet Gynecol Gyamfi-Bannerman 119 555 2012 10.1097/AOG.0b013e31824758f6 Effect of antenatal corticosteroids on respiratory morbidity in singletons after late-preterm birth
Cochrane Database Syst Rev Doyle 1 2009 10.1002/14651858.CD004661.pub3 Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus
N Engl J Med Epstein 271 391 1964 10.1056/NEJM196408202710803 Late Vascular Effects of Toxemia of Pregnancy
Am J Obstet Gynecol Cusimano 210 438 2014 10.1016/j.ajog.2013.12.001 The maternal health clinic: an initiative for cardiovascular risk identification in women with pregnancy-related complications
Obstet Gynecol Sattar 89 403 1997 10.1016/S0029-7844(96)00514-5 Lipoprotein subfraction concentrations in preeclampsia: pathogenic parallels to atherosclerosis
Hypertension Kvehaugen 58 63 2011 10.1161/HYPERTENSIONAHA.111.172387 Endothelial function and circulating biomarkers are disturbed in women and children after preeclampsia
Am Heart J McDonald 156 918 2008 10.1016/j.ahj.2008.06.042 Cardiovascular sequelae of preeclampsia/eclampsia: a systematic review and meta-analyses
Am J Obstet Gynecol Hermes 208 474 2013 10.1016/j.ajog.2013.02.016 Cardiovascular risk factors in women who had hypertensive disorders late in pregnancy: a cohort study
Hypertension Veerbeek 65 600 2015 10.1161/HYPERTENSIONAHA.114.04850 Cardiovascular disease risk factors after early-onset preeclampsia, late-onset preeclampsia, and pregnancy-induced hypertension
Curr Opin Obstet Gynecol Williams 15 465 2003 10.1097/00001703-200312000-00002 Pregnancy: a stress test for life
Circulation Jacobs 111 383 2005 10.1161/01.CIR.0000155289.62829.0F Evaluating and managing cardiovascular disease in women: understanding a woman's heart
Am J Kidney Dis McDonald 55 1026 2010 10.1053/j.ajkd.2009.12.036 Kidney disease after preeclampsia: a systematic review and meta-analysis
Obstet Gynecol Surv Hoedjes 65 631 2010 10.1097/OGX.0b013e3182077f64 Effect of postpartum lifestyle interventions on weight loss, smoking cessation, and prevention of smoking relapse: a systematic review
BMC Pregnancy Childbirth Heidrich 13 61 2013 10.1186/1471-2393-13-61 Preeclampsia and long-term risk of cardiovascular disease: what do obstetrician-gynecologists know?
J Obstet Gynaecol Can MacDonald 29 705 2007 10.1016/S1701-2163(16)32601-9 Hypertensive disorders of pregnancy and long-term risk of hypertension: what do Ontario prenatal care providers know, and what do they communicate?
Hypertens Pregnancy Young 31 50 2012 10.3109/10641955.2010.544955 Physicians' knowledge of future vascular disease in women with preeclampsia
Am J Obstet Gynecol Cusimano 210 438 2014 10.1016/j.ajog.2013.12.001 The Maternal Health Clinic: an initiative for cardiovascular risk identification in women with pregnancyrelated complications
J Obstet Gynecol Neonatal Nurs Spratling 43 179 2014 10.1111/1552-6909.12296 Effect of an educational intervention on cardiovascular disease risk perception among women with preeclampsia
BJOG Berks 120 924 2013 10.1111/1471-0528.12191 Risk of cardiovascular disease after pre-eclampsia and the effect of lifestyle interventions: a literature-based study
J Womens Health (Larchmt) Rautio 23 506 2014 10.1089/jwh.2013.4520 Lifestyle intervention in prevention of type 2 diabetes in women with a history of gestational diabetes mellitus: one-year results of the FIN-D2D project
J Am Coll Cardiol Ahmed 63 1815 2014 10.1016/j.jacc.2014.02.529 Pre-eclampsia and future cardiovascular risk among women: a review
Best Pract Res Clin Obstet Gynaecol Firoz 25 537 2011 10.1016/j.bpobgyn.2011.04.002 Pre-eclampsia in low and middle income countries
IEEE J Biomed Health Inform Dunsmuir 18 1857 2014 10.1109/JBHI.2014.2301156 Development of mHealth applications for pre-eclampsia triage
Lancet Villar 357 1551 2001 10.1016/S0140-6736(00)04722-X WHO antenatal care randomised trial for the evaluation of a new model of routine antenatal care
Reprod Health Vogel 10 19 2013 10.1186/1742-4755-10-19 Antenatal care packages with reduced visits and perinatal mortality: a secondary analysis of the WHO Antenatal Care Trial
Reprod Health Hofmeyr 10 20 2013 10.1186/1742-4755-10-20 Antenatal care packages with reduced visits and perinatal mortality: a secondary analysis of the WHO antenatal care trial - Comentary: routine antenatal visits for healthy pregnant women do make a difference
BMC Res Notes Cormick 7 920 2014 10.1186/1756-0500-7-920 Gaps between calcium recommendations to prevent pre-eclampsia and current intakes in one hospital in Argentina
Am J Clin Nutr Belizen 33 2202 1980 10.1093/ajcn/33.10.2202 The relationship between calcium intake and edema-, proteinuria-, and hypertension-getosis: an hypothesis
BJOG Hofmeyr 121 951 2014 10.1111/1471-0528.12613 Low-dose calcium supplementation for preventing pre-eclampsia: a systematic review and commentary
Int J Gynaecol Obstet Goldenberg 113 91 2011 10.1016/j.ijgo.2011.01.002 Lessons for low-income regions following the reduction in hypertension-related maternal mortality in high-income countries
Lancet Althabe 385 629 2015 10.1016/S0140-6736(14)61651-2 A population-based, multifaceted strategy to implement antenatal corticosteroid treatment versus standard care for the reduction of neonatal mortality due to preterm birth in low-income and middle-income countries: the ACT cluster-randomised trial
Acta Obstet Gynecol Scand Goldenberg 94 148 2015 10.1111/aogs.12533 Reducing maternal mortality from preeclampsia and eclampsia in low-resource countries-what should work?
Lancet Steegers 376 631 2010 10.1016/S0140-6736(10)60279-6 Pre-eclampsia
Hypertension Myatt 63 1293 2014 10.1161/HYPERTENSIONAHA.113.02664 Strategy for standardization of preeclampsia research study design
Placenta Burton 35 9 2014 10.1016/j.placenta.2013.11.005 Optimising sample collection for placental research
Am J Perinatol Mol 30 163 2013 Global alignment, coordination and collaboration in perinatal research: the Global Obstetrics Network (GONet) Initiative
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.